
ACR 2026 data link circulating protein signatures to PsA disease activity and treatment response with deucravacitinib.

Vinod Chandran, MD, PhD is a professor of medicine at the University of Toronto and director of the Gladman Krembil Psoriatic Arthritis Program at the Schroeder Arthritis Institute, University Health Network.